Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)-Reference-Cited by-同舟云学术

Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)

Published:2018-09 Issue:9 Volume:62 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Alastruey-Izquierdo Ana¹²^ORCID,Alcazar-Fuoli Laura¹²,Rivero-Menéndez Olga¹,Ayats Josefina³²,Castro Carmen⁴,García-Rodríguez Julio⁵,Goterris-Bonet Lidia⁶,Ibáñez-Martínez Elisa⁷,Linares-Sicilia María José⁸,Martin-Gomez M. Teresa⁶,Martín-Mazuelos Estrella⁴,Pelaez Teresa⁹,Peman Javier⁷^ORCID,Rezusta Antonio¹⁰,Rojo Susana¹¹,Tejero Rocio⁸,Anza Diego Vicente¹²¹³¹⁴,Viñuelas Jesús¹⁰,Zapico Maria Soledad¹²,Cuenca-Estrella Manuel¹

Affiliation:

1. Instituto Salud Carlos III, National Centre for Microbiology, Madrid, Spain

2. Spanish Network for Research in Infectious Diseases, Instituto de Salud Carlos III, Madrid, Spain

3. Hospital Universitari de Bellvitge, Barcelona, Spain

4. Hospital Universitario Virgen de Valme, Seville, Spain

5. Hospital Universitario La Paz, Madrid, Spain

6. Hospital Universitario Vall d'Hebron, Barcelona, Spain

7. Hospital Universitario La Fe, Valencia, Spain

8. Hospital Universitario Reina Sofía, Córdoba, Spain

9. Hospital General Universitario Gregorio Marañón, Madrid, Spain

10. Hospital Universitario Miguel Servet, Zaragoza, Spain

11. Hospital Universitario Central de Asturias, Oviedo, Spain

12. Hospital Universitario Donostia, San Sebastian, Spain

13. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain

14. Universidad del País Vasco UPV/EHU, Vizcaya, Spain

Abstract

Antifungal resistance is increasing by the emergence of intrinsically resistant species and by the development of secondary resistance in susceptible species. A previous study performed in Spain revealed levels of azole resistance in molds of between 10 and 12.7%, but secondary resistance in Aspergillus fumigatus was not detected.

Funder

Fondo de Investigaciones Sanitarias

Gilead Sciences

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00358-18

Reference51 articles.

1. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients

2. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects